Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2015

Mar 5, 2015

30583_dirs_2015-03-05_5e617256-0b53-4aa1-a3c4-7dc125eb974d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-03-03

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-03-03 Common Stock A 39600 Acquired 254757 Direct
2015-03-05 Common Stock M 10000 $12.99 Acquired 52279 Indirect
2015-03-05 Common Stock S 10000 $113.7016 Disposed 42279 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-03-03 Stock Option (right to buy) Common Stock $108.36 A 90500 Acquired 2025-03-02 Common Stock (90500) Direct
2015-03-05 Stock Option (right to buy Common Stock) $12.99 M 10000 Disposed 2016-05-10 Common Stock (10000) Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy Common Stock) $12.99 2016-05-10 Common Stock (10000) 10000 Indirect
Stock Option (right to buy Common Stock) $12.99 2016-05-10 Common Stock (10000) 10000 Indirect
Stock Option (right to buy Common Stock) $12.99 2016-05-10 Common Stock (10000) 10000 Indirect
Stock Option (right to buy Common Stock) $12.99 2016-05-10 Common Stock (10000) 10000 Indirect
Stock Option (right to buy Common Stock) $12.99 2016-05-10 Common Stock (20000) 20000 Indirect

Footnotes

F1: Restricted stock units granted on March 3, 2015. Price not applicable.

F2: The reporting person an his spouse act as trustees for the Bienaime Family Trust

F3: The price in column 4 is an average weighted price. The price actually received ranged from $113.27 to $114.00. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.

F4: Option grant vests 6/48ths on September 3, 2015, and 1/48th on the 3rd day of every month thereafter

F5: Original option grant vests 6/48ths on November 11, 2006, and 1/48th on the 11th of every month thereafter.

F6: The reporting person's spouse is the trustee of each child's trust.